2026 Q2 Portfolio Activity
In 2026 Q2, Anchorage Capital Group, L.L.C. maintained a portfolio of 3 distinct positions.
Position History
hover any row below to update
Loading…
Total Positions
3
Quarter
2026 Q2
Top Holding
N/A (77.6%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-3 of 3
Anchorage Capital Group, L.L.C. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
EQUIPMENTSHARE ...
|
|
Unknown | 77.56% | 82.97% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
17,770,560 | $349,369,210 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
S
SENTINELONE INC
|
Technology | 18.60% | 14.58% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
4,937,053 | $83,781,789 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNA
GINKGO BIOWORKS...
|
Healthcare | 3.84% | 2.45% |
#3
Prev: #3
|
3.5 |
—
|
no change | no change |
P
S
|
1,746,363 | $17,306,457 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-3 of 3 holdings